NeoPharm’s CINTREDEKIN BESUDOTOX Highlighted In Presentations At The Congress Of Neurological Surgeons (CNS) Annual Meeting

WHO/WHAT: NEOPHARM, Inc. (NASDAQ/NM: NEOL) clinical data presentations on CINTREDEKIN BESUDOTOX (“IL13-PE38QQR”) WHERE: Congress of Neurological Surgeons (CNS) 2006 Annual Meeting October 7-12, 2006 McCormick Place Convention Center Chicago, Ill.

MORE ON THIS TOPIC